Revision of Prior Period [Axis] Revision of Prior Period [Axis] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Statistical Measurement [Domain] Statistical Measurement [Domain] Class of warrant or right, conversion terms, threshold trading days Class Of Warrant Or Right, Conversion Terms, Threshold Trading Days Class Of Warrant Or Right, Conversion Terms, Threshold Trading Days Award Timing Predetermined Award Timing Predetermined [Flag] Loan Facility, June 30, 2025 Loan Facility, June 30, 2025 [Member] Loan Facility, June 30, 2025 Entity File Number Entity File Number Additional paid-in capital Additional Paid-in Capital [Member] SOFR floor Debt Instrument, Minimum Variable Rate, SOFR Floor Debt Instrument, Minimum Variable Rate, SOFR Floor Impairment and Disposal of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Tabular List, Table Tabular List [Table Text Block] Leases [Abstract] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Exit fee percentage Line Of Credit Facility, Exit Fee Percentage Line Of Credit Facility, Exit Fee Percentage Warrants issued, delayed draw commitment amount, percentage Class Of Warrant Or Right, Warrants Issued, Delayed Draw Commitment Amount, Percentage Class Of Warrant Or Right, Warrants Issued, Delayed Draw Commitment Amount, Percentage Nature of Business [Line Items] Nature of Business [Line Items] Nature of Business [Line Items] Restricted stock units issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Options Equity Instruments, Issued Share-based Compensation Arrangement by Share-based Payment Award, Non-Options Equity Instruments, Issued Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Warrants outstanding (in shares) Warrants outstanding, beginning balance (in shares) Warrants outstanding, ending balance (in shares) Class of Warrant or Right, Outstanding Net loss per common share, basic (in dollars per share) Earnings Per Share, Basic Revenue base redemption liability Revenue Base Redemption Liability Revenue Base Redemption Liability Adjustment to Compensation: Adjustment to Compensation [Axis] Schedule of Reverse Recapitalization [Table] Schedule of Reverse Recapitalization [Table] Schedule of Reverse Recapitalization Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Trade payables and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Common stock reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Accrued liabilities - clinical trials Accrued Clinical Trial Liability, Current Accrued Clinical Trial Liability, Current Loan Facility, Initial Commitment Amount Loan Facility, Initial Commitment Amount [Member] Loan Facility, Initial Commitment Amount Inventory Disclosure [Abstract] 24 to 36 Months Prepayment Premium Rate, Period Three [Member] Prepayment Premium Rate, Period Three Purchase agreement, maximum shares allowed, percentage of average daily volume Common Stock, Share Price, Percentage Of Average Daily Volume Common Stock, Share Price, Percentage Of Average Daily Volume Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] SPAC Warrants SPAC Warrants [Member] SPAC Warrants Measurement Input Type [Domain] Measurement Input Type [Domain] Adjustment to Compensation, Amount Adjustment to Compensation Amount Share reserve increase, percentage of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Percentage Of Stock, Fully Diluted Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Percentage Of Stock, Fully Diluted Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Options to purchase common stock Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Research and Development Research and Development Expense, Policy [Policy Text Block] Preferred stock conversion ratio Preferred Stock, Convertible, Conversion Ratio Cash, Cash Equivalents, and Restricted Cash Cash and Cash Equivalents, Policy [Policy Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Original issue price (in dollars per share) Preferred Stock, Issued Price Per Share Preferred Stock, Issued Price Per Share Total stockholders’ deficit Balance, beginning of period Balance, end of period Equity, Attributable to Parent Paid-in-kind interest Debt Instrument, Paid-In-Kind Interest Percentage Debt Instrument, Paid-In-Kind Interest Percentage Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Insider Trading Policies and Procedures [Line Items] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Beginning balance Ending balance Fair Value, Measurement Reconciliation, Liability Value Fair Value, Measurement Reconciliation, Liability Value Warrant Liabilities Warrant Liability, Policy [Policy Text Block] Warrant Liability, Policy Proceeds from sale of common stock (in shares) Issuances (in shares) Stock Issued During Period, Shares, New Issues Current assets: Assets, Current [Abstract] Total liabilities and stockholders’ deficit Liabilities and Equity Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Maximum shares of common stock allowed under Purchase Agreement (in shares) Standby Equity Purchase Agreement, Maximum Amount Of Shares Authorized Standby Equity Purchase Agreement, Maximum Amount Of Shares Authorized Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Concentrations of Credit Risk and Other Risks and Uncertainties Concentration Risk, Credit Risk, Policy [Policy Text Block] Liabilities and Stockholders’ Deficit Liabilities and Equity [Abstract] Other income (expense): Other Nonoperating Income (Expense) [Abstract] Maximum Maximum [Member] Accounting Policies [Abstract] Class of warrant or right, redemption price (in dollars per share) Class of Warrant or Right, Redemption Price Class of Warrant or Right, Redemption Price Dynavax Purchase Asset Acquisition [Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount March 31, 2026 Revenue Base Redemption Feature, Period Five [Member] Revenue Base Redemption Feature, Period Five Debt Instrument [Line Items] Debt Instrument [Line Items] Change in Unrealized (Gains) Losses Change in unrealized gain Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Temporary Equity [Line Items] Temporary Equity [Line Items] Liquidation preference (in dollars per share) Preferred Stock, Liquidation Preference Per Share Accrued payroll Accrued Salaries, Current Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Depreciation Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Proceeds from the disposal of property and equipment Proceeds from Sale of Property, Plant, and Equipment Series A Convertible Preferred Stock, floor conversion price (in dollars per share) Preferred Stock, Conversion Price, Floor Preferred Stock, Conversion Price, Floor Tranche Two Derivative Instrument, Period Two [Member] Derivative Instrument, Period Two Statement of Stockholders' Equity [Abstract] Number of warrants exchanged (in shares) Class Of Warrant Or Right, Warrants Exchanged Class Of Warrant Or Right, Warrants Exchanged Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Accrued incentives Accrued Bonuses, Current Fair value of revenue base redemption liability related to OrbiMed debt Revenue Base Redemption Feature In Connection With Debt, Value Revenue Base Redemption Feature In Connection With Debt, Value Measurement Input Type [Axis] Measurement Input Type [Axis] Name Measure Name Secured Debt Secured Debt [Member] Schedule of Changes in Fair Value of Outstanding Warrant and Tranche Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Private Placement And Working Capital Warrants Private Placement And Working Capital Warrants [Member] Private Placement And Working Capital Warrants Number of leases Lessee, Number Of Operating Leases Lessee, Number Of Operating Leases Warrants and rights outstanding, net of issuance costs Warrants and Rights Outstanding, Net Of Issuance Costs Warrants and Rights Outstanding, Net Of Issuance Costs Revenue base redemption liability Product Revenue Base Redemption [Member] Product Revenue Base Redemption Award Timing Method Award Timing Method [Text Block] Award Type [Axis] Award Type [Axis] Long-term debt, beginning balance Long-term debt, ending balance Long-Term Debt Exercises (in shares) Class Of Warrant Or Right, Warrants Exercised Class of Warrant or Right, Warrants Exercised Total assets Assets Threshold number of business days before sending notice of redemption to warrant holders Class Of Warrant Or Right, Conversion Days Notice Class Of Warrant Or Right, Conversion Days Notice Private Placement Warrants Private Placement Warrants Private Warrants [Member] Private Warrants Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Continuing Operation [Abstract] Share-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Trading Symbol Trading Symbol Nature of Business [Table] Nature of Business [Table] Nature of Business [Table] Contingent Earnout Liability Business Combination [Policy Text Block] Default rate Debt Instrument, Debt Default, Rate Debt Instrument, Debt Default, Rate Income Taxes Income Tax, Policy [Policy Text Block] Entity Address, City or Town Entity Address, City or Town Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Inventory Inventory Disclosure [Text Block] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount RSUs Restricted Stock Units (RSUs) [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Undeclared cumulative dividends Preferred Stock Dividends, Undeclared Cumulative Dividends Preferred Stock Dividends, Undeclared Cumulative Dividends Number of lease renewal options exercised Lessee, Operating Lease, Number Of Renewal Options Exercised Lessee, Operating Lease, Number Of Renewal Options Exercised Entity Emerging Growth Company Entity Emerging Growth Company Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Warrants Warrant [Member] Common stock, shares authorized, standby equity purchase agreement (in shares) Common Stock, Shares Authorized, Standby Equity Purchase Agreement Common Stock, Shares Authorized, Standby Equity Purchase Agreement Right-of-use assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Stock options outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Contingent earnout liability Contingent Earnout Liability [Member] Contingent Earnout Liability Class of warrant or right, conversion terms, threshold consecutive trading days Class of Warrant or Right, Conversion Terms, Threshold Consecutive Trading Days Class of Warrant or Right, Conversion Terms, Threshold Consecutive Trading Days Level 2 Fair Value, Inputs, Level 2 [Member] Change in fair value of warrants and SEPA liabilities Gain (loss) on change in fair value Derivative, Gain (Loss) on Derivative, Net Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Stock options issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Issued Share-based Compensation Arrangement by Share-based Payment Award, Options, Issued Increase in common stock reserve for future issuance (in shares) Common Stock, Period Increase (Decrease) in Capital Shares Reserved for Future Issuance Common Stock, Period Increase (Decrease) In Capital Shares Reserved For Future Issuance Administrative fee Debt Instrument, Fee Amount Common stock, shares outstanding (in shares) Balances, beginning of period (in shares) Balances, end of period (in shares) Common Stock, Shares, Outstanding Allowance for credit losses Amount charged (recovered) to costs and expenses Accounts Receivable, Credit Loss Expense (Reversal) Purchase agreement, sales price, percentage of market price during three consecutive trading days Share Price As Percentage Of Market Price With Advance Notice, Option Two Share Price As Percentage Of Market Price With Advance Notice, Option Two Plan Name [Axis] Plan Name [Axis] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Document Information [Table] Document Information [Table] PEO PEO [Member] Lease Contractual Term [Domain] Lease Contractual Term [Domain] Accrued vacation Accrued Vacation, Current Interest income Investment Income, Interest Shares purchased in ESPP offering (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Accrued taxes Accrued Income Taxes, Current Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Exercise of options Stock Issued During Period, Value, Stock Options Exercised Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Current stock price Stock price Measurement Input, Share Price [Member] Derivative Instruments and Hedging Activities Disclosure [Abstract] Accumulated deficit Retained Earnings [Member] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Share-Based Payment Arrangement [Abstract] Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period Cash, cash equivalents and restricted cash, Total cash, cash equivalents and restricted cash shown in the Condensed Consolidated Statements of Cash Flows Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income tax benefit (expense) Income Tax Expense (Benefit) Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Product revenue base, minimum amount required Line Of Credit Facility, Product Revenue Base, Minimum Threshold Amount Line Of Credit Facility, Product Revenue Base, Minimum Threshold Amount Sale of Stock [Domain] Sale of Stock [Domain] Revenue Base Redemption Liability Revenue Base Redemption Liability, Policy [Policy Text Block] Revenue Base Redemption Liability, Policy Warrant and SEPA liabilities Derivative Liability, Noncurrent Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Retirements/Conversions (in shares) Temporary Equity, Stock Retired Or Converted During Period, Shares Temporary Equity, Stock Retired Or Converted During Period, Shares Estimated dividend yield Dividend yield Measurement Input, Expected Dividend Rate [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Number of warrants after split Class Of Warrant Or Right, Warrant Split, Number Of New Warrants Class Of Warrant Or Right, Warrant Split, Number Of New Warrants Shares issuable under the SEPA Standby Equity Purchase Agreement (SEPA) [Member] Standby Equity Purchase Agreement (SEPA) Organization, Consolidation and Presentation of Financial Statements [Abstract] Royalties as a percentage of net sales, under sales threshold Asset Acquisition, Royalty Percentage, Under Threshold Amount Asset Acquisition, Royalty Percentage, Under Threshold Amount Reduction in the carrying amount of right-of-use assets Operating Lease, Right-of-Use Asset, Periodic Reduction Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Issuances (in shares) Temporary Equity, Shares Issued During Period Temporary Equity, Shares Issued During Period Proceeds from private placement Proceeds from Issuance of Private Placement Proceeds from the exercise of stock options for common stock Proceeds from Stock Options Exercised Change in fair value of SEPA, warrant, and revenue base redemption liabilities Gain (Loss) On Change In Fair Value Of Warrants And Other Liabilities Gain (Loss) On Change In Fair Value Of Warrants And Other Liabilities Schedule of Error Corrections and Prior Period Adjustments Schedule of Error Corrections and Prior Period Adjustments [Table Text Block] City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Undeclared dividends on Series A preferred stock Preferred Stock Dividends, Income Statement Impact Commitments and Contingencies Disclosure [Abstract] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Proceeds from the issuance of debt Proceeds from lines of credit Proceeds from Long-Term Lines of Credit Share-based compensation arrangement by share-based payment award, automatic increase, percentage of total shares Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Total Shares Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Total Shares General and administrative General and Administrative Expense Unrecognized compensation expense, options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash used in operating activities Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Property, plant and equipment, useful life Property, Plant and Equipment, Useful Life Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Subsequent Event Subsequent Event [Member] Shares returned Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Shares Returned From Options Exercised, Correction Of Clerical Error Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Shares Returned From Options Exercised, Correction Of Clerical Error Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Expected draws Derivative liability, measurement input Derivative Liability, Measurement Input Exchange ratio (in shares) Recapitalization Exchange Ratio Recapitalization Exchange Ratio Lease Contractual Term [Axis] Lease Contractual Term [Axis] Equity Components [Axis] Equity Components [Axis] Entity Ex Transition Period Entity Ex Transition Period Nature of Business Nature of Operations [Text Block] June 30, 2025 Revenue Base Redemption Feature, Period Two [Member] Revenue Base Redemption Feature, Period Two Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Accretion of exit fee liability Accretion Expense Lessee, number of finance leases Lessee, Number Of Finance Leases Lessee, Number Of Finance Leases Number of reportable segments Number of Reportable Segments Contingent earnout liability, measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Warrants, term Earnout shares vesting requirement, vesting period Warrants and Rights Outstanding, Term Advertising Advertising Cost [Policy Text Block] Other Performance Measure, Amount Other Performance Measure, Amount Change in Unrealized (Gains) Losses Fair Value, Liability, Still Held, Unrealized Gain (Loss) Fair Value, Liability, Still Held, Unrealized Gain (Loss) Schedule of Restricted Cash Restrictions on Cash and Cash Equivalents [Table Text Block] Debt issuance costs Cash issuance costs Payments of Debt Issuance Costs Entity Address, State or Province Entity Address, State or Province June 30, 2026 and each Fiscal Quarter ending thereafter Revenue Base Redemption Feature, Period Six And Thereafter [Member] Revenue Base Redemption Feature, Period Six And Thereafter Payments on finance lease liabilities Finance Lease, Principal Payments Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Reverse Recapitalization [Line Items] Reverse Recapitalization [Line Items] Reverse Recapitalization Earnout period, threshold trading days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Trading Days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Trading Days Total current liabilities Liabilities, Current Share reserve increase, number of years Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Number of Years Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Number of Years Individual: Individual [Axis] Leases Lessee, Finance Leases [Text Block] Royalties as a percentage of sales, over threshold amount Asset Acquisition, Royalty Percentage, Over Threshold Amount Asset Acquisition, Royalty Percentage, Over Threshold Amount Automatic conversion, anniversary Preferred Stock, Automatic Conversion, Period Preferred Stock, Automatic Conversion, Period Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activity Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Right-of-use assets Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Maximum aggregate milestone payments per development milestone Asset Acquisition, Maximum Milestone Amount Asset Acquisition, Maximum Milestone Amount Effective federal tax rate Effective Income Tax Rate Reconciliation, Percent Entity Interactive Data Current Entity Interactive Data Current Westminster Facility Westminster Facility [Member] Westminster Facility Plan Name [Domain] Plan Name [Domain] Unrecognized compensation expense, recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Stock net yet issued, price per share (in dollars per share) Sale Of Stock, Not Yet Issued, Price Per Share Sale Of Stock, Not Yet Issued, Price Per Share Exercise of options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Stockholders’ deficit: Equity [Abstract] Prepayment Premium Rate, Period [Domain] Prepayment Premium Rate, Period [Domain] Prepayment Premium Rate, Period [Domain] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Schedule of Share-Based Compensation Plan Balances Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Standby Equity Purchase Agreement Derivatives, Policy [Policy Text Block] Warrant holder support for Warrant Agreement Class Of Warrant Or Right, Percentage of Warrants, Tender Agreement Class Of Warrant Or Right, Percentage of Warrants, Tender Agreement Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Revenue base redemption feature, amount Revenue base redemption liability Revenue Base Redemption Feature, Amount Revenue Base Redemption Feature, Amount Class of Warrant or Right [Table] Class of Warrant or Right [Table] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Leases Lessee, Leases [Policy Text Block] Expected share price volatility Expected volatility Measurement Input, Price Volatility [Member] Issuances (Settlements) Fair Value, Measurement Reconciliation, Liability, Purchases, (Sales), Issuances, (Settlements) Fair Value, Measurement Reconciliation, Liability, Purchases, (Sales), Issuances, (Settlements) Dynavax Technologies Dynavax Technologies [Member] Dynavax Technologies Other assets Other Assets, Noncurrent Entity Central Index Key Entity Central Index Key SEPA derivative liability Standby Equity Purchase Agreement (SEPA) Derivative Liability [Member] Standby Equity Purchase Agreement (SEPA) Derivative Liability PEO Name PEO Name Sale of stock, consideration received on transaction Sale of Stock, Consideration Received on Transaction Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Supplemental disclosures of cash flow information: Supplemental Cash Flow Elements [Abstract] Finished goods Inventory, Finished Goods, Gross Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Warrant liability Warrant Liability Warrant Liability Accounts Receivable and Customer Concentrations Accounts Receivable [Policy Text Block] SEPA derivative liability Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Contingent earnout liability Business Combination, Contingent Consideration, Liability, Noncurrent Arrangement Duration Trading Arrangement Duration Exercise price of warrants (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise Price Award Exercise Price Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Entity Filer Category Entity Filer Category Local Phone Number Local Phone Number Class of Stock [Domain] Class of Stock [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Unrecognized compensation expense, RSUs Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Subsequent Event Type [Axis] Subsequent Event Type [Axis] Share-Based Compensation Share-Based Payment Arrangement [Text Block] Number of debt increments available to be drawn Number Of Debt Increments Available To Be Drawn Number Of Debt Increments Available To Be Drawn Assets Assets [Abstract] Long-term debt, net of unamortized discount and debt issuance costs Long-Term Debt, Excluding Current Maturities Underlying Security Market Price Change Underlying Security Market Price Change, Percent Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Debt Instrument [Axis] Debt Instrument [Axis] Financial Instruments Fair Value Disclosures [Text Block] 2024 Awards 2024 Stock-Based Compensation Awards [Member] 2024 Stock-Based Compensation Awards Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Fair Value, Liabilities Measurement Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measurement Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measurement Reconciliation, Calculation Entity Address, Address Line One Entity Address, Address Line One Research and development Research and development expenses Research and Development Expense Beginning Balance Ending Balance Accounts Receivable, Allowance for Credit Loss, Current Common stock exchange for warrants (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Revenue Base Redemption Feature, Period [Axis] Revenue Base Redemption Feature, Period [Axis] Revenue Base Redemption Feature, Period Class of Warrant or Right [Roll Forward] Class Of Warrant Or Right [Roll Forward] Class Of Warrant Or Right Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] Contingent Earnout Liability Standby Equity Purchase Agreement Derivative Instruments and Hedging Activities Disclosure [Text Block] Convertible Preferred Stock Preferred Stock [Text Block] Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Derivative liability, measurement input Warrant Liability, Measurement Input Warrant Liability, Measurement Input Convertible preferred stock, beginning balance (in shares) Convertible preferred stock, ending balance (in shares) Temporary Equity, Shares Outstanding Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Purchase agreement period Standby Equity Purchase Agreement, Term Standby Equity Purchase Agreement, Term Alliance program, term Alliance Program, Term Alliance Program, Term Schedule of Long-Term Debt Instruments Schedule of Long-Term Debt Instruments [Table Text Block] Expected draws Measurement Input, Expected Draws [Member] Measurement Input, Expected Draws Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Quarterly Report Document Quarterly Report Record issuance costs Issuance costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Revision of Prior Period [Domain] Revision of Prior Period [Domain] Schedule of Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Number of equity incentive plans Number of Equity Incentive Plans Number of Equity Incentive Plans RSU weighted average fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Temporary Equity Disclosure [Abstract] Restatement Determination Date: Restatement Determination Date [Axis] Conversion price, second automatic reset Preferred Stock, Conversion Price, Automatic Reset Duration, Second Reset Preferred Stock, Conversion Price, Automatic Reset Duration, Second Reset Earnout shares vesting percentage Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Vesting Percentage Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Vesting Percentage Non-PEO NEO Non-PEO NEO [Member] Revenue recognition, rebates recognized Revenue Recognition, Rebates Recognized Revenue Recognition, Rebates Recognized Preferred stock, dividend rate, percentage Preferred Stock, Dividend Rate, Percentage Interest expense Interest Expense, Debt Sale of Stock [Axis] Sale of Stock [Axis] Warrants and Rights Note Disclosure [Abstract] Working capital warrants Working Capital Warrants Working Capital Warrants Working Capital Warrants [Member] Working Capital Warrants Name Trading Arrangement, Individual Name Previously Reported Previously Reported [Member] Award Type [Domain] Award Type [Domain] Equity Awards Adjustments Equity Awards Adjustments [Member] Advertising expense Advertising Expense Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Initial OrbiMed Warrant, Substitute Warrant Certificate Number Two Initial OrbiMed Warrant, Substitute Warrant Certificate Number Two [Member] Initial OrbiMed Warrant, Substitute Warrant Certificate Number Two Share-based compensation arrangement by share-based payment award, automatic increase, percentage of initial share reserve Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Initial Share Reserve Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Initial Share Reserve Compensation Amount Outstanding Recovery Compensation Amount Temporary Equity, by Class of Stock [Table] Temporary Equity, by Class of Stock [Table] Revenue Base Redemption Feature, Period [Domain] Revenue Base Redemption Feature, Period [Domain] Revenue Base Redemption Feature, Period [Domain] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] OrbiMed Warrants liability OrbiMed Warrants OrbiMed Warrants [Member] OrbiMed Warrants Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Preferred stock Preferred stock Preferred Stock [Member] Outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Outstanding Schedule of Accounts Receivable, Allowance for Credit Loss Accounts Receivable, Allowance for Credit Loss [Table Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Restricted cash (included in Other assets) Restricted Cash, Noncurrent Initial OrbiMed Warrant Initial OrbiMed Warrant [Member] Initial OrbiMed Warrant Royalties, sales threshold amount Asset Acquisition, Royalties, Sales Threshold Amount Asset Acquisition, Royalties, Sales Threshold Amount Percentage of preferred stock that were tendered Preferred Stock, Percentage Of Outstanding Stock Tendered Preferred Stock, Percentage Of Outstanding Stock Tendered Change in fair value of contingent earnout liability Change in fair value of contingent earnout liability Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Number of lease renewal options Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options Employee Stock Employee Stock [Member] Non-cash interest expense Noncash Interest Expense Noncash Interest Expense Asset Acquisition [Line Items] Asset Acquisition [Line Items] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Purchase agreement, number of trading days used for measurement of market price Common Stock, Share Price, Market Price, Number Of Consecutive Trading Days Common Stock, Share Price, Market Price, Number Of Consecutive Trading Days Preferred stock conversion (in shares) Preferred Stock Conversion, Shares Preferred Stock Conversion, Shares Sales and marketing Selling and Marketing Expense Liability Class [Axis] Liability Class [Axis] December 31, 2025 Revenue Base Redemption Feature, Period Four [Member] Revenue Base Redemption Feature, Period Four Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Common stock warrants Common Stock Warrant [Member] Common Stock Warrant Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Inventory, net Increase (Decrease) in Inventories Inventory, net Inventory, net Inventory, Net Schedule of Convertible Preferred Stock Temporary Equity [Table Text Block] Warrants to purchase common stock (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Minimum Minimum [Member] Deposits Increase (Decrease) in Deposits Outstanding Long-term lease liabilities Lease Liability, Noncurrent Lease Liability, Noncurrent Net Loss per Share Earnings Per Share, Policy [Policy Text Block] Company Selected Measure Name Company Selected Measure Name Debt Debt Disclosure [Text Block] Preferred Stock, Convertible Series A, $0.0001 par value per share, $10.00 liquidation value per share. Authorized 10,000,000 shares at June 30, 2025 and December 31, 2024, respectively; issued and outstanding, 3,594,002 and 3,985,002 shares at June 30, 2025, and December 31, 2024, respectively. Preferred Stock, Value, Issued Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] All Executive Categories All Executive Categories [Member] Common stock, $0.0001 par value per share. Authorized 400,000,000 shares at June 30, 2025 and December 31, 2024, respectively; issued and outstanding, 37,983,259 and 31,279,264 shares at June 30, 2025, and December 31, 2024, respectively. Common Stock, Value, Issued Stock converted, reverse recapitalization (in shares) Stock Converted, Reverse Recapitalization Stock Converted, Reverse Recapitalization Standby equity purchase agreement, maximum allowable percentage of outstanding common stock Standby Equity Purchase Agreement, Maximum Allowable Percentage Of Outstanding Common Stock Standby Equity Purchase Agreement, Maximum Allowable Percentage Of Outstanding Common Stock Commitments And Contingencies Commitments and Contingencies Disclosure [Text Block] Weighted average common shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Subsequent OrbiMed Warrants Subsequent OrbiMed Warrants [Member] Subsequent OrbiMed Warrants Segment Reporting Segment Reporting, Policy [Policy Text Block] Commitments and contingencies Commitments and Contingencies Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Class of warrant or right, threshold number of days for warrants to be transferable Class of Warrant or Right, Threshold Number of Days for Warrants to be Transferable Class of Warrant or Right, Threshold Number of Days for Warrants to be Transferable Bannockburn Facility Bannockburn Facility [Member] Bannockburn Facility Change in fair value of OrbiMed Warrants and revenue base redemption liabilities Gain (Loss) On Change In Fair Value Of Revenue Base Redemption And Warrant Liability Gain (Loss) On Change In Fair Value Of Revenue Base Redemption And Warrant Liability Entity Small Business Entity Small Business Accounting Standards Update and Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Common stock issuance costs Payments of Stock Issuance Costs Preferred stock, conversion price (in dollars per share) Preferred Stock, Convertible, Conversion Price Income Tax Disclosure [Abstract] Share-based compensation arrangement by share-based payment award, automatic increase period Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase Period Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase Period Preferred stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Preferred Stock, Shares Outstanding Document Transition Report Document Transition Report Tranche Four Derivative Instrument, Period Four [Member] Derivative Instrument, Period Four Public Warrants, Private Placement Warrants And Working Capital Warrants Public Warrants, Private Placement Warrants And Working Capital Warrants [Member] Public Warrants, Private Placement Warrants And Working Capital Warrants Underlying Securities Award Underlying Securities Amount Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date Business Combination Reverse Recapitalization Disclosure [Text Block] Reverse Recapitalization Disclosure PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Income Taxes Income Tax Disclosure [Text Block] Prepaid warrant issuance costs Prepaid Warrant Issuance Costs Prepaid Warrant Issuance Costs Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Operating lease liabilities Increase (Decrease) in Operating Lease Liability Non-cash interest expense Amortization of Debt Discount (Premium) Document Type Document Type Restricted stock units outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Net Loss Per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Additional paid-in capital Additional Paid in Capital Asset Acquisition [Domain] Asset Acquisition [Domain] Proceeds from the issuance of common stock Proceeds from Issuance of Common Stock Revenue Revenue from Contract with Customer, Excluding Assessed Tax All Individuals All Individuals [Member] Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Fair Value Disclosures [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Upfront payment Asset Acquisition, Consideration Transferred Name Forgone Recovery, Individual Name Share-based compensation arrangement by share-based payment award, expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Total current assets Assets, Current Cash paid for interest expense Interest Paid, Capitalized, Investing Activity Purchase agreement, sales price, percentage of market price Share Price As Percentage Of Market Price Commencing On Advance Notice Date Share Price As Percentage Of Market Price Commencing On Advance Notice Date Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Undrawn fee, percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Stock options exercise price, percentage of fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Exercise price Measurement Input, Exercise Price [Member] Number of OrbiMed's operating entities Class Of Warrant Or Right, Number Of Operating Entities Holding Warrants Class Of Warrant Or Right, Number Of Operating Entities Holding Warrants Private Placement Private Placement [Member] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Net loss attributable to common stockholders Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Entity Information [Line Items] Entity Information [Line Items] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Current liabilities: Liabilities, Current [Abstract] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Fair value of warrants issued related to OrbiMed debt Warrants Issued In Connection With Debt, Value Warrants Issued In Connection With Debt, Value Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] 12 to 24 Months Prepayment Premium Rate, Period Two [Member] Prepayment Premium Rate, Period Two Level 1 Fair Value, Inputs, Level 1 [Member] Net loss per common share, diluted (in dollars per share) Earnings Per Share, Diluted Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Title of 12(b) Security Title of 12(b) Security Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Paid in kind interest, term Debt Instrument, Paid-In-Kind Interest, Term Debt Instrument, Paid-In-Kind Interest, Term Supplemental disclosures of non-cash items: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Sale of stock (in shares) Sale of Stock, Number of Shares Issued in Transaction PIK interest PIK interest Paid-in-Kind Interest Earnings Per Share [Abstract] Earnings Per Share [Abstract] Issuances (in shares) Class Of Warrant Or Right, Shares Issued During Period Class Of Warrant Or Right, Shares Issued During Period Prepaid expenses Increase (Decrease) in Prepaid Expense Derecognition of finance lease right-of-use asset Derecognition Of Finance Lease Right-Of-Use Asset Derecognition Of Finance Lease Right-Of-Use Asset Asset Acquisition [Table] Asset Acquisition [Table] Gross profit Gross Profit Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Within 12 Months Prepayment Premium Rate, Period One [Member] Prepayment Premium Rate, Period One Debt Instrument, Activity [Roll Forward] Debt Instrument, Activity [Roll Forward] Debt Instrument, Activity Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Debt instrument, prepayment premium rate Debt Instrument, Prepayment Premium Rate Debt Instrument, Prepayment Premium Rate Derivative instrument, contingent consideration, liability, earnout period Derivative Instrument, Contingent Consideration, Liability, Earnout Period Derivative Instrument, Contingent Consideration, Liability, Earnout Period After 48 Months Prepayment Premium Rate, Period Five [Member] Prepayment Premium Rate, Period Five Warrant redemption condition, share price (in dollars per share) Class Of Warrant Or Right, Conversion Stock Price Threshold Class Of Warrant Or Right, Conversion Stock Price Threshold Income taxes Income Taxes Paid, Net Shares unvested (in shares) Contingent Consideration, Liability, Shares Number of Shares Unvested Award Timing Disclosures [Line Items] Schedule of Components of Inventory Schedule of Inventory, Current [Table Text Block] Purchase agreement, ownership limitation Class Of Warrant Or Right, Ownership Limitation Class Of Warrant Or Right, Ownership Limitation Rent payments Lessee, Operating Lease, Liability, to be Paid Lease renewal term Lessee, Operating Lease, Renewal Term Property and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization 2009 Plan 2009 Plan [Member] 2009 Plan Derivative Instrument, Period [Axis] Derivative Instrument, Period [Axis] Derivative Instrument, Period Net loss available to common stockholders Net loss Net loss available to common stockholders Net loss available to common stockholders Net Income (Loss) Attributable to Parent Expiration Date Trading Arrangement Expiration Date September 30, 2025 Revenue Base Redemption Feature, Period Three [Member] Revenue Base Redemption Feature, Period Three RSUs and PSUs Restricted And Performance Stock Units Restricted Stock Units And Performance Shares [Member] Restricted Stock Units And Performance Shares Accrued liabilities - general Other Accrued Liabilities, Current Share-based payment arrangement, contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Public Warrants Public Warrants Public Warrants [Member] Public Warrants Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Adoption Date Trading Arrangement Adoption Date Sale of stock, authorized amount Sale Of Stock, Authorized Amount, Value Sale Of Stock, Authorized Amount, Value Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Accounts receivable Increase (Decrease) in Accounts Receivable Inventory Inventory, Policy [Policy Text Block] Entity Current Reporting Status Entity Current Reporting Status Expected term (years) Measurement Input, Expected Term [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Continuing Operation [Abstract] Retirements/Conversions (in shares) Class of Warrant Or Right, Conversion And Retirements Of Convertible Securities Class of Warrant Or Right, Conversion And Retirements Of Convertible Securities Loss from operations Loss from operations Operating Income (Loss) Issuances (Settlements) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements) Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Subsequent OrbiMed Warrants, Entity One Subsequent OrbiMed Warrants, Entity One [Member] Subsequent OrbiMed Warrants, Entity One Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Proceeds from the issuance of preferred stock Proceeds from Issuance of Convertible Preferred Stock Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Loan Facility Loan Facility [Member] Loan Facility Reserve for obsolete inventory Inventory Valuation Reserves Current Fiscal Year End Date Current Fiscal Year End Date Class of Stock [Axis] Class of Stock [Axis] Class of warrant or right, number of securities called by each warrant or right (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Error correction adjustment Revision of Prior Period, Error Correction, Adjustment [Member] Tranche One Derivative Instrument, Period One [Member] Derivative Instrument, Period One Subsequent Event Type [Domain] Subsequent Event Type [Domain] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Payables and Accruals [Abstract] Available for Issue (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Statement [Table] Statement [Table] Other expense, net Other Nonoperating Income (Expense) Earnout shares vesting requirement, weighted average price per share (in dollars per share) Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Stock Price Trigger Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Stock Price Trigger Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Number of trading days, VWAP Preferred Stock, Number of Trading Days, Volume Weighted Average Price Preferred Stock, Number of Trading Days, Volume Weighted Average Price Options, weighted average fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] 2023 Plan 2023 Plan [Member] 2023 Plan Record exchange warrants Adjustments to Additional Paid in Capital, Warrant Issued Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] 36 to 48 Months Prepayment Premium Rate, Period Four [Member] Prepayment Premium Rate, Period Four Commercial Milestone Commercial Milestone [Member] Commercial Milestone Conversion price, first automatic reset Preferred Stock, Conversion Price, Automatic Reset Duration, First Reset Preferred Stock, Conversion Price, Automatic Reset Duration, First Reset Subsequent OrbiMed Warrants, Entity Two Subsequent OrbiMed Warrants, Entity Two [Member] Subsequent OrbiMed Warrants, Entity Two Cash and Cash Equivalents [Abstract] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Purchase agreement, number of days used for measurement of average daily trading volume Common Stock, Share Price, Average Daily Volume, Number Of Trading Days Common Stock, Share Price, Average Daily Volume, Number Of Trading Days Sale of stock, price per share (in dollars per share) Sale of Stock, Price Per Share Options and RSU's outstanding (in shares) Authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Preferred stock available for future issuance (in shares) Preferred Stock, Capital Shares Reserved for Future Issuance Leases Lessee, Operating Leases [Text Block] Termination Date Trading Arrangement Termination Date Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Reverse Recapitalization [Abstract] Reverse Recapitalization Schedule of Warrants Outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Sale of stock, shares to be issued in transaction (in shares) Sale Of Stock, Number Of Shares To Be Issued In Transaction Sale Of Stock, Number Of Shares To Be Issued In Transaction Weighted average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Cost of goods sold Cost of Product and Service Sold Outstanding warrant liabilities Warrants and Rights Outstanding Payments for milestone Payments for Asset Acquisition, Milestone Amount Payments for Asset Acquisition, Milestone Amount Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Debt Disclosure [Abstract] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Amortization of debt issuance costs Amortization of debt issuance costs Amortization of Debt Issuance Costs Entity Tax Identification Number Entity Tax Identification Number Asset Acquisition [Axis] Asset Acquisition [Axis] Write-off of uncollectible receivables Accounts Receivable, Allowance for Credit Loss, Writeoff Commercial Milestone Type [Domain] Commercial Milestone Type [Domain] Commercial Milestone Type [Domain] Derivative Instrument, Period [Domain] Derivative Instrument, Period [Domain] Derivative Instrument, Period [Domain] Series A Convertible Preferred Stock Series A Convertible Preferred Stock [Member] Series A Convertible Preferred Stock Short-term lease liabilities Lease Liability, Current Lease Liability, Current Commercial Milestone Type [Axis] Commercial Milestone Type [Axis] Commercial Milestone Type University Of Texas MD Anderson Cancer Center University Of Texas MD Anderson Cancer Center [Member] University Of Texas MD Anderson Cancer Center Trade payables Accounts Payable, Trade, Current Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares issued (in shares) Common Stock, Shares, Issued Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Cash, Cash Equivalents and Restricted Cash Cash and Cash Equivalents Disclosure [Text Block] Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Earnout period, threshold consecutive trading days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Consecutive Trading Days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Consecutive Trading Days Tranche Three Derivative Instrument, Period Three [Member] Derivative Instrument, Period Three Use of Estimates Use of Estimates, Policy [Policy Text Block] Interest expense Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name Expected probability of draws Measurement Input, Expected Probably of Draws [Member] Measurement Input, Expected Probably of Draws Raw materials Inventory, Raw Materials, Gross Initial OrbiMed Warrant, Substitute Warrant Certificate Number One Initial OrbiMed Warrant, Substitute Warrant Certificate Number One [Member] Initial OrbiMed Warrant, Substitute Warrant Certificate Number One Total liabilities Liabilities Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Commitment fee percentage Line of Credit Facility, Commitment Fee Percentage Fixed asset purchases included in trade payables and accrued expenses Capital Expenditures Incurred but Not yet Paid Line of credit maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Exercise of options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Net Of Shares Returned Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Net Of Shares Returned Prepayment Premium Rate, Period [Axis] Prepayment Premium Rate, Period [Axis] Prepayment Premium Rate, Period Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Operating expenses: Operating Expenses [Abstract] Prepaid expenses Prepaid Expense, Current Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Other current liabilities Other Liabilities, Current Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Proceeds from sale of common stock Issuance of stock Stock Issued During Period, Value, New Issues Statement [Line Items] Statement [Line Items] Standby Equity Purchase Agreement Standby Equity Purchase Agreement [Member] Standby Equity Purchase Agreement Fixed asset purchase through exchange of finance lease right-of-use asset Fixed Asset Purchase Through Exchange Of Finance Lease Right-Of-Use Asset Fixed Asset Purchase Through Exchange Of Finance Lease Right-Of-Use Asset Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalent Number of commercial milestones Asset Acquisition, Number of Commercial Milestones Asset Acquisition, Number of Commercial Milestones Counterparty Name [Axis] Counterparty Name [Axis] Additional number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Common stock, $0.0001 par value Common stock Common Stock [Member] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Warrants Warrants Liabilities [Text Block] Warrants Liabilities Loan Facility, December 31, 2025 Loan Facility, December 31, 2025 [Member] Loan Facility, December 31, 2025 Increase in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation